These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Risk of congenital abnormalities in children born to women with ulcerative colitis: a population-based, case-control study. Nørgård B; Puho E; Pedersen L; Czeizel AE; Sørensen HT Am J Gastroenterol; 2003 Sep; 98(9):2006-10. PubMed ID: 14499779 [TBL] [Abstract][Full Text] [Related]
44. Prenatal diagnosis and genetic screening--integration into prenatal care. Rappaport VJ Obstet Gynecol Clin North Am; 2008 Sep; 35(3):435-58, ix. PubMed ID: 18760229 [TBL] [Abstract][Full Text] [Related]
45. Teratology: from science to birth defects prevention. Rasmussen SA; Erickson JD; Reef SE; Ross DS Birth Defects Res A Clin Mol Teratol; 2009 Jan; 85(1):82-92. PubMed ID: 19067401 [TBL] [Abstract][Full Text] [Related]
46. Association of maternal pre-pregnancy weight with birth defects: evidence from a case-control study in Western Australia. Oddy WH; De Klerk NH; Miller M; Payne J; Bower C Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):11-5. PubMed ID: 19281573 [TBL] [Abstract][Full Text] [Related]
47. [The pathogenesis of prenatal infections]. FLAMM H Bibl Microbiol; 1960; 1():3-8. PubMed ID: 13823362 [No Abstract] [Full Text] [Related]
48. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. Meirow D; Schiff E J Natl Cancer Inst Monogr; 2005; (34):21-5. PubMed ID: 15784816 [TBL] [Abstract][Full Text] [Related]
49. Pre-natal paediatrics. DODS L Med J Aust; 1952 Feb; 1(7):205-11. PubMed ID: 14918715 [No Abstract] [Full Text] [Related]
50. [Role of experimentally induced developmental anomalies in the elucidation of the etiology of congenital defects in the human]. DIUREISVEMI PK; ORT MCh Eksp Khirurgiia; 1963; 8():44-9. PubMed ID: 14028095 [No Abstract] [Full Text] [Related]
51. Birth defects and glycolysis. Villee CA N Engl J Med; 1984 Jan; 310(4):254-5. PubMed ID: 6690941 [No Abstract] [Full Text] [Related]
52. [Electric shock therapy during pregnancy and embryopathy. Electro-traumatic or viral embryopathy? Apropos of a clinical observation]. SCHACHTER M Acta Paedopsychiatr; 1960 Dec; 27():289-92. PubMed ID: 13747140 [No Abstract] [Full Text] [Related]
53. [Current knowledge on embryopathies with exogenous malformations in man. Conclusions aimed at physicians and drug industry]. WIEDEMANN HR Med Welt; 1962 Jun; 24():1343-9. PubMed ID: 14006766 [No Abstract] [Full Text] [Related]
55. [Which are the medicamentous products contraindicated during pregnancy?]. LACOMME M Maternite; 1961 Dec; 10():369-72 contd. PubMed ID: 14461416 [No Abstract] [Full Text] [Related]
56. [The role of the virus in the etiology of congenital malformations]. AUZEPY P Rev Prat; 1961 Jul; 11():2069-71. PubMed ID: 13685240 [No Abstract] [Full Text] [Related]
57. [On the method of recording and studying the dynamics of the incidence of developmental defects in humans]. Glotov NV Vestn Akad Med Nauk SSSR; 1965; 20(9):22-5. PubMed ID: 5870537 [No Abstract] [Full Text] [Related]
58. The influence of toxoplasmosis on the incidence of congenital facial malformations, preliminary report. ERDELYI R Plast Reconstr Surg (1946); 1957 Oct; 20(4):306-10. PubMed ID: 13494208 [No Abstract] [Full Text] [Related]
59. [Fetal abnormalities and abortions and their relation to toxoplasmosis]. PYTEL I; DYMOWSKA Z; KOZLOWSKA D Wiad Parazytol; 1958; 4(5-6):419-20; English transl 420-1. PubMed ID: 13604155 [No Abstract] [Full Text] [Related]
60. Congenital toxoplasmosis and the passive transfer of antibodies to a non-affected child. PHILIPSBORN HF; REANEY BV Q Bull Northwest Univ Med Sch; 1955; 29(2):182-5. PubMed ID: 14371981 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]